Skip to main content

Advertisement

Table 1 Descriptive statistics describing the baseline demographic and illness features for the three groups

From: A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placebo

  1. Note: NAC, N-acetyl cysteine; CT, combination nutraceutical treatment